Evidence map›Paper›PMID 36792758›Full record

ArticleNeurochemical research2023

NMDA Receptor Activation and Ca

Arthur Cardoso Souto, Matheus Heidemann Tempone, Lyslie Azeredo Coutinho Gonçalves, Vladimir Pedro Peralva Borges-Martins, Maria Carolina Peixoto-Rodrigues, Ana Clara Oliveira Damascena, Gabriel Ferraz, Alex Christian Manhães, Newton Gonçalves Castro, Ricardo Augusto de Melo Reis and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Arthur Cardoso SoutoLaboratório de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, Universidade Federal Fluminense, Inst Biomédico - Rua São João Batista, 187, Sala 416, Centro, Niterói, CEPRJ, 24020-005, Brazil.
Matheus Heidemann TemponeLaboratório de Neuroquímica. IBCCF, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0001-9863-3313
Lyslie Azeredo Coutinho GonçalvesLaboratório de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, Universidade Federal Fluminense, Inst Biomédico - Rua São João Batista, 187, Sala 416, Centro, Niterói, CEPRJ, 24020-005, Brazil.
Vladimir Pedro Peralva Borges-MartinsLaboratório de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, Universidade Federal Fluminense, Inst Biomédico - Rua São João Batista, 187, Sala 416, Centro, Niterói, CEPRJ, 24020-005, Brazil.ORCID http://orcid.org/0000-0002-5213-0363
Maria Carolina Peixoto-RodriguesLaboratório de Neuroplasticidade, Departamento de Neurobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, Brazil.ORCID http://orcid.org/0000-0002-7685-2897
Ana Clara Oliveira DamascenaLaboratório de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, Universidade Federal Fluminense, Inst Biomédico - Rua São João Batista, 187, Sala 416, Centro, Niterói, CEPRJ, 24020-005, Brazil.
Gabriel FerrazLaboratório de Farmacologia Molecular, ICB, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Alex Christian ManhãesLaboratório de Neurofisiologia, IBRAG, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0003-4629-8343
Newton Gonçalves CastroLaboratório de Farmacologia Molecular, ICB, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0001-9570-7428
Ricardo Augusto de Melo ReisLaboratório de Neuroquímica. IBCCF, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0001-9689-4085
Ana Lucia Marques VenturaLaboratório de Neuroquímica, Departamento de Neurobiologia, Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0002-4323-4451
Regina Célia Cussa KubruslyLaboratório de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, Universidade Federal Fluminense, Inst Biomédico - Rua São João Batista, 187, Sala 416, Centro, Niterói, CEPRJ, 24020-005, Brazil. reginakubrusly@id.uff.br.ORCID http://orcid.org/0000-0002-6016-2197
Universidade Federal Fluminense · BRUniversidade Federal do Rio de Janeiro · BRUniversidade do Estado do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotinic receptors are present in the retina of different vertebrates, and in the chick retina, it is present during early development throughout to post-hatching. These receptors are activated by nicotine, an alkaloid with addictive and neurotransmitter release modulation properties, such as GABA signaling. Here we evaluated the mechanisms of nicotine signaling in the avian retina during the development of neuron-glia cells at a stage where synapses are peaking. Nicotine almost halved [

Indexed as

NicotineReceptors, NicotinicAnimalsCalciumExcitatory Amino Acid Antagonistsgamma-Aminobutyric AcidReceptors, N-Methyl-D-AspartateRetinaCalciumExcitatory Amino Acid Antagonistsgamma-Aminobutyric AcidNicotineReceptors, NicotinicReceptors, N-Methyl-D-AspartateAcetylcholineGABAGABA transportGlutamateNicotineNicotinic receptors

Identifiers

PMID36792758
OpenAlexW4320912284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.